Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases
Clinical trial NCT05807893 · COMPLETED
Trial details
- NCT number
- NCT05807893
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-14
- Primary completion
- 2024-03-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.